Menstrual blood loss is an independent determinant of hemoglobin and ferritin levels in premenopausal blood donors.
anemia
blood donor health
ferritin
heavy menstrual bleeding
hemoglobin
iron deficiency
menstruation
pictorial blood assessment chart
Journal
Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343
Informations de publication
Date de publication:
10 Jun 2024
10 Jun 2024
Historique:
revised:
27
05
2024
received:
26
02
2024
accepted:
27
05
2024
medline:
10
6
2024
pubmed:
10
6
2024
entrez:
10
6
2024
Statut:
aheadofprint
Résumé
To prevent blood donors from developing iron deficiency (ferritin <15 μg/L) and subsequent anemia (hemoglobin <120 g/L), blood services rely on information about known risk factors, including the donor's sex and age. For example, while Finnish women are able to donate whole blood with a minimum donation interval of 91 days, women in the 18 to 25-year-old age group are recommended to donate no more than once per year. Menstrual blood loss is not accounted for in blood donation interval recommendations, despite being a known risk factor of iron deficiency. We aim to investigate to what extent menstrual bleeding is associated with ferritin and hemoglobin levels in female blood donors, and quantify the association of other menstruation-related variables not currently accounted for by blood services (i.e., use of hormonal contraception, heavy menstrual bleeding) with iron deficiency or anemia. The study population consisted of 473 premenopausal and 491 postmenopausal Dutch whole blood donors. Exclusion criteria were current pregnancy, BMI ≥50, ferritin ≥200, pictorial blood assessment chart (PBAC) ≥400, and age <18 or ≥70 years. Menstrual blood loss was quantified using a PBAC, a semiquantitative method to evaluate the number of used menstrual products and the degree of staining. We identified predictors of log(ferritin)/hemoglobin and iron deficiency/anemia using Bayesian linear and logistic regression models and quantified the average percentage of variance in log(ferritin) and hemoglobin explained by the covariates. Menstrual blood loss accounted for most of the explained variance in hemoglobin (8%) and second only to the number of days since last donation for ferritin (8%). Heavy menstrual bleeding (PBAC ≥150, OR = 3.56 [1.45-8.85], prevalence 13%) was associated with anemia, and use of levonorgestrel-releasing intrauterine device was negatively associated with iron deficiency (OR = 0.06 [0.01-0.44]). After statistical control for menstrual blood loss, age was not associated with iron status. Menstrual blood loss and blood donation were the most important determinants of iron status in premenopausal women. Thus, results suggest that accounting for menstrual blood loss in donation interval guidelines may benefit blood donors.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Finska Läkaresällskapet
Organisme : Helsingin Yliopisto
ID : Tutkijalääkäriohjelma K26
Organisme : Punainen Risti Veripalvelu
Organisme : Stichting Sanquin Bloedvoorziening
ID : PPOC-14-028
Organisme : Stichting Sanquin Bloedvoorziening
ID : PPOC-19-02
Informations de copyright
© 2024 The Author(s). Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).
Références
Nieto‐Calvache AJ, Quintero‐Santacruz M, Macia‐Mejía C, López‐Girón MC, Vergara‐Galliadi LM, Ariza F. Dangerous shortage of blood banks as an indirect effect of SARS‐CoV‐2: an obstetrics perspective. Int J Gynaecol Obstet. 2020;151:424‐430.
Peuranpää P, Heliövaara‐Peippo S, Fraser I, Paavonen J, Hurskainen R. Effects of anemia and iron deficiency on quality of life in women with heavy menstrual bleeding. Acta Obstet Gynecol Scand. 2014;93:654‐660.
Vuk T, Magnussen K, de Kort W, et al. International forum: an investigation of iron status in blood donors. Blood Transfus. 2017;15:20‐41.
Clement M, Shehu E, Chandler T. The impact of temporary deferrals on future blood donation behavior across the donor life cycle. Transfusion. 2021;61:1799‐1808.
Friedman AJ, Chen Z, Ford P, et al. Iron deficiency anemia in women across the life span. J Womens Health (Larchmt). 2012;21:1282‐1289.
Kim I, Yetley EA, Calvo MS. Variations in iron‐status measures during the menstrual cycle. Am J Clin Nutr. 1993;58:705‐709.
Mullen J, Baekken L, Bergström H, Björkhem Bergman L, Ericsson M, Ekström L. Fluctuations in hematological athlete biological passport biomarkers in relation to the menstrual cycle. Drug Test Anal. 2020;12:1229‐1240.
Keller MF, Harrison ML, Lalande S. Impact of menstrual blood loss and oral contraceptive use on oxygen‐carrying capacity. Med Sci Sports Exerc. 2020;52:1414‐1419.
Hallberg L, Högdahl AM, Nilsson L, Rybo G. Menstrual blood loss—a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand. 1966;45:320‐351.
Munro MG, Critchley HOD, Broder MS, Fraser IS. FIGO classification system (PALM‐COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113:3‐13.
Bernardi LA, Ghant MS, Andrade C, Recht H, Marsh EE. The association between subjective assessment of menstrual bleeding and measures of iron deficiency anemia in premenopausal African‐American women: a cross‐sectional study. BMC Womens Health. 2016;16:50.
Shapley M, Jordan K, Croft PR. An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract. 2004;54:359‐363.
Fraser IS, Mansour D, Breymann C, Hoffman C, Mezzacasa A, Petraglia F. Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. Int J Gynaecol Obstet. 2015;128:196‐200.
Mansour D, Hofmann A, Gemzell‐Danielsson K. A review of clinical guidelines on the management of iron deficiency and iron‐deficiency anemia in women with heavy menstrual bleeding. Adv Ther. 2021;38:201‐225.
Carver A, Chell K, Davison TE, Masser BM. What motivates men to donate blood? A systematic review of the evidence. Vox Sang. 2018;113:205‐219.
Rigas AS, Sørensen CJ, Pedersen OB, et al. Predictors of iron levels in 14,737 Danish blood donors: results from the Danish Blood Donor Study. Transfusion. 2014;54:789‐796.
Beck KL, Conlon CA, Kruger R, et al. Blood donation, being Asian, and a history of iron deficiency are stronger predictors of iron deficiency than dietary patterns in premenopausal women. Biomed Res Int. 2014;2014:652860.
Cable RG, Glynn SA, Kiss JE, et al. Iron deficiency in blood donors: analysis of enrollment data from the REDS‐II Donor Iron Status Evaluation (RISE) study. Transfusion. 2011;51:511‐522.
Magnay JL, O'Brien S, Gerlinger C, Seitz C. Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review. BMC Womens Health. 2020;20:24.
Janssen CA, Scholten PC, Heintz AP. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol. 1995;85:977‐982.
Timmer TC, de Groot R, Habets K, et al. Donor InSight: characteristics and representativeness of a Dutch cohort study on blood and plasma donors. Vox Sang. 2019;114:117‐128.
Lobier M, Castrén J, Niittymäki P, Palokangas E, Partanen J, Arvas M. The effect of donation activity dwarfs the effect of lifestyle, diet and targeted iron supplementation on blood donor iron stores. PLoS One. 2019;14:e0220862.
Higham JM, Shaw RW. Clinical associations with objective menstrual blood volume. Eur J Obstet Gynecol Reprod Biol. 1999;82:73‐76.
Quinn SD, Higham J. Outcome measures for heavy menstrual bleeding. Women's Health (Lond Engl). 2016;12:21‐26.
Ekroos SM. GitHub repository: menstrual blood loss is an important determinant of Hb and ferritin levels in premenopausal blood donors. 2023. https://github.com/FRCBS [cited 2023 Jun 3]. https://github.com/FRCBS/EffectOfMenstruationInDutchBloodDonors
Groemping U. Relative importance for linear regression in R: the package relaimpo. J Stat Softw. 2006;17(1 SE‐Articles):1‐27. https://www.jstatsoft.org/index.php/jss/article/view/v017i01
Bürkner PC. brms: an R package for Bayesian multilevel models using Stan. J Stat Softw. 2017;80(1 SE‐Articles):1‐27. https://www.jstatsoft.org/index.php/jss/article/view/v080i01
Bayesplot: plotting Bayesian models. http://mc‐stan.org/bayesplot/
Harvey LJ, Armah CN, Dainty JR, et al. Impact of menstrual blood loss and diet on iron deficiency among women in the UK. Br J Nutr. 2005;94:557‐564.
Napolitano M, Dolce A, Celenza G, et al. Iron‐dependent erythropoiesis in women with excessive menstrual blood losses and women with normal menses. Ann Hematol. 2014;93:557‐563.
Heath AL, Skeaff CM, Williams S, Gibson RS. The role of blood loss and diet in the aetiology of mild iron deficiency in premenopausal adult New Zealand women. Public Health Nutr. 2001;4:197‐206.
Bofill Rodriguez M, Lethaby A, Jordan V. Progestogen‐releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2020;6:CD002126.
Mawet M, Nollevaux F, Nizet D, et al. Impact of a new levonorgestrel intrauterine system, Levosert(®), on heavy menstrual bleeding: results of a one‐year randomised controlled trial. Eur J Contracept Reprod Health Care. 2014;19:169‐179.
Lowe RF, Prata N. Hemoglobin and serum ferritin levels in women using copper‐releasing or levonorgestrel‐releasing intrauterine devices: a systematic review. Contraception. 2013;87:486‐496.
Alfaro‐Magallanes VM, Romero‐Parra N, Barba‐Moreno L, et al. Serum iron availability, but not iron stores, is lower in naturally menstruating than in oral contraceptive athletes. Eur J Sport Sci. 2023;23:231‐240.
Milman N, Rosdahl N, Lyhne N, Jørgensen T, Graudal N. Iron status in Danish women aged 35–65 years. Relation to menstruation and method of contraception. Acta Obstet Gynecol Scand. 1993;72:601‐605.
Toffol E, Heikinheimo O, Jousilahti P, et al. Metabolomics profile of 5649 users and nonusers of hormonal intrauterine devices in Finland. Am J Obstet Gynecol. 2022;227:603.e1‐603.e29.
de Graaf A, Beets GCN. Vijfentwintig jaar geboorteregeling [Twenty‐five Years of Birth Control]. Vol 62. Bevolkingstrends; 2015:1‐19. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjs4fjB04L7AhVktIsKHYQ8DlkQFnoECBUQAQ&url=https%3A%2F%2Fwww.cbs.nl%2F‐%2Fmedia%2Fimported%2Fdocuments%2F2015%2F20%2F2015‐vijfentwintig‐jaar‐geboorteregeling.pdf%3Fla%3Dnl‐nl&usg=AOvV
Warner PE, Critchley HOD, Lumsden MA, Campbell‐Brown M, Douglas A, Murray GD. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow‐up data. Am J Obstet Gynecol. 2004;190:1216‐1223.